Jayachandra Reddy Atluri

Jayachandra Reddy Atluri

Active Director Whole-Time Director DIN 02070592
DIN 02070592 First appointment Sep 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Sep 2004
Shareholding value •••• Premium profile

About Jayachandra Reddy Atluri

Data last updated:

Jayachandra Reddy Atluri is a Whole-Time Director at Axis Clinicals Limited (since 2009) and Director at Clini Vigil Pharma Solutions Private Limited (since 2019). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹387 Cr; the largest is Axis Clinicals Limited at ₹387 Cr (FY 2025). Earlier, Jayachandra Reddy Atluri was a Whole-Time Director at Trident Life Sciences Limited (2004–2009) and Director at Axis Clinicals India Limited (from 2012).

DIN 02070592
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 08 Sep 2004
Oldest Company Age 19 yrs
Largest company Axis Clinicals Limited · ₹387 Cr (FY 2025)
Combined revenue ₹387 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axis Clinicals Limited U73100TG2007PLC052813
Whole-Time Director06 Jul 20092007₹387 Cr (FY 2025)Active
Director11 Sep 20192019₹1.4 Lakh (FY 2021)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trident Life Sciences Limited U24239TG2004PLC044102
Whole-Time Director08 Sep 20042004Amalgamated
Axis Clinicals India Limited U73100TG2012PLC082225
Director30 Jul 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Jayachandra Reddy Atluri

Directorship timeline

Open interactive timeline →
Axis Clinicals Limited
Clini Vigil Pharma Solutions Private Limited
Axis Clinicals India Limited
Trident Life Sciences Limited
Premium access

Shareholding and investment profile for Jayachandra Reddy Atluri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayachandra Reddy Atluri

Jayachandra Reddy Atluri currently holds 2 directorships: Axis Clinicals Limited (Whole-Time Director, since 06 Jul 2009, revenue ₹387 Cr (FY 2025)); Clini Vigil Pharma Solutions Private Limited (Director, since 11 Sep 2019, revenue ₹1.4 Lakh (FY 2021)).

Jayachandra Reddy Atluri was first appointed on 08 Sep 2004 as Whole-Time Director at Trident Life Sciences Limited. The most recent appointment on record is 11 Sep 2019 at Clini Vigil Pharma Solutions Private Limited.

The 2 current companies of Jayachandra Reddy Atluri that report revenue have a combined latest revenue of ₹387 Cr: Axis Clinicals Limited ₹387 Cr (FY 2025); Clini Vigil Pharma Solutions Private Limited ₹1.4 Lakh (FY 2021).

Jayachandra Reddy Atluri held 2 earlier board appointments: Trident Life Sciences Limited (Whole-Time Director, 08 Sep 2004 to 18 Sep 2009); Axis Clinicals India Limited (Director, from 30 Jul 2012).

The current boards of Jayachandra Reddy Atluri's companies include China Venka Reddy Kotta (Axis Clinicals Limited), Lakshmi Vara Koka (Axis Clinicals Limited), Mallikarjuna Reddy Kantabathuni (Axis Clinicals Limited), Naga Venkata Kesavarapu (Axis Clinicals Limited), Nisha Sahu (Axis Clinicals Limited), Panibhushan Reddy Bonga (Axis Clinicals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available